Shilpa Medicare Share Price

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.As of 14 Jun 2026, Shilpa Medicare share price is ₹546.75. The stock opened at ₹549.90, compared to its previous close of ₹538.85. During today's trading session, Shilpa Medicare share price moved in the range of ₹538.20 to ₹556.75, with an average price of ₹547.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹538.20 and a high of ₹556.75. On the performance front, Shilpa Medicare share price has increased by 65.11% over the last six months and is up 13.60% on a year-on-year basis.

The market capitalization of Shilpa Medicare is ₹10,683 Crs, with a P/E ratio of 43.9 and a dividend yield of 0.11%.